
Sign up to save your podcasts
Or


Or Imbar, the co-founder and CEO of Metabit, discusses the development of an AI-driven platform for interpreting cardiopulmonary tests, specifically CPET. The conversation covers the challenges of training AI, regulatory approvals, the impact on physician workflow, and the future of cardiopulmonary diagnostics.
By Anna NesterovaOr Imbar, the co-founder and CEO of Metabit, discusses the development of an AI-driven platform for interpreting cardiopulmonary tests, specifically CPET. The conversation covers the challenges of training AI, regulatory approvals, the impact on physician workflow, and the future of cardiopulmonary diagnostics.